We hypothesized that p53 inactivation in carcinoma cells could lead to actin cytoskeleton reorganization by shifting the β-/γ-actin ratio towards γ-actin, thereby stimulating tumor progression and metastasis. This evidence concerns the gene TP53 and carcinoma.